Ribosomal protein L32 pseudogene 33 (RPL32P33)

Ribosomal protein L32 pseudogene 33 (RPL32P33) is classified as a processed (non-coding) pseudogene related to the canonical ribosomal protein L32 gene (RPL32) in humans[1][7]. RPL32 is a functional, protein-coding gene that contributes to the large 60S subunit of the ribosome and is involved in cytoplasmic protein synthesis[1][7]. However, RPL32P33 and other RPL32 pseudogenes are non-functional genetic loci generated by retrotransposition events and do not encode functional proteins[1]. No evidence supports the use of RPL32P33 as a therapeutic target, receptor, enzyme, transporter, or transcription factor. No literature was identified to suggest a biological function, disease association, or drug interaction for RPL32P33 specifically[2][4]. Some pseudogenes of ribosomal proteins may have regulatory roles in rare or specific cellular contexts or in cancers, but RPL32P33 is not described in these roles in available sources. A different pseudogene, RPL32P3 (not RPL32P33), has reported regulatory functions in glioma but is a distinct locus[3]. RPL32P33 is most appropriately annotated as a non-coding pseudogene, not a direct molecular target for therapy or drug design[1][7]. If more structured data is required, further targeted database curation would be needed as platform results did not yield gene cards, function, pharmacology, or disease role for RPL32P33 specifically. Note: This gene is a pseudogene and not a target for therapeutic intervention. RPL32P3, not RPL32P33, is the pseudogene with reported biological effects in published studies[3]. If "RPL32P33" is misspelled or not intended as a pseudogene, additional clarification would be required for accurate curation.